MSQ Health, through its wholly owned subsidiary Akacia Medical, will collaborate with th Coega SEZ to build a fit for purpose 5 900m2 manufacturing plant that is set to create more than 100 new jobs locally.
MSQ Health, is seeking to support the local economy by investing over R100 million in a 5 900m2 Akacia Medical manufacturing plant that will produce cost-effective quality medical products for both the local and international markets at the Coega Special Economic Zone. Construction of the manufacturing plant is underway and Akacia Medical and the Coega Development Corporation are discussing further ways to ensure this is a viable and sustainable facility that will support manufacturing jobs in the Eastern Cape for the foreseeable future.
Akacia Medical is a subsidiary of MSQ Health and one of the largest medical manufacturers in South Africa, producing more than 2 600 different product lines of medical devices and medical consumables. Boasting two ISO accredited manufacturing plants in Cape Town and Port Elizabeth whilst employing more than 400 employees that manufacture, market and distribute medical and surgical health products.
“When the decision came to expand our manufacturing facilities, we were clear that South Africa still offers the best option for locating our manufacturing plant. Local production achieves our vision of “Innovation that Cares” by creating sustainable manufacturing jobs, deepening our manufacturing capabilities and ensuring the supply of high quality medical products. We are happy that the Coega Development Corporation has come on board to build a larger custom-built manufacturing plant at the Coega SEZ, which will allow us to service the growing demand for high quality, cost-effective medical products. The investment in new technology and machines will deliver increased production capacity whilst increasing efficiencies and lowering the cost of production. Akacia Medical will be ideally positioned to support the implementation of the NHI and delivery of cost-effective healthcare to South Africans”, said Mr Moss Ngoasheng Group Chairman of MSQ Health.
It has been reported that the ‘local medical device industry remains underdeveloped’ with ‘imports catering to 90% of market by value’. 1 The South African medical device industry is ranked in the top 30 largest in the world yet it is serviced by imports mainly from the US and Asian countries. 2 MSQ Health, through Akacia Medical, is positioned to change this dynamic by adding more manufacturing capacity through this Coega investment.
”It gives us great pleasure to be welcoming yet another investor at the world class Coega Special Economic Zone (SEZ). Our 9003ha zone is positioned and ready to support this investment together with our existing 43 operational investors,” says Christopher Mashigo, CDC Executive Manager Business Development.
The Akacia Medical manufacturing plant will add diversity of investors in the zone, which will further reinforce our value proposition in terms of Coega being the gateway to local and international markets.” As the leading catalysts for championing of the socio-economic development in the region, we could not have attracted a more strategic and well-aligned investor in Akacia Medical, given their plans to support the implementation of NHI that will deliver cost-effective healthcare to South Africans. This investment will bring the private sector investment at Coega in excess of R7.1 billion, and further strengthen Coega as the leading SEZ in Africa,” concludes Mashigo
Alan Straton
Latest posts by Alan Straton (see all)
- Damaged Cars Wanted Pays Gauteng Sellers Before the Tow Truck Leaves - 16 November 2026
- Border Management Conference and Expo 2026 Brings Government, Industry and Regional Partners Together in Pretoria on 18 November - 15 November 2026
- Are You Hiring More People to Manage Inefficient Processes? - 15 November 2026
- Mann Made Media Puts AI Automation and AI Video on the Table for 2027 Plans - 15 November 2026
- Balwin’s Black November Savings Land on Four Pretoria East Estates - 14 November 2026
